Imaging Guided Surgery using Fluorescently Labeled Cetuximab
Imaging Guided Surgery using Fluorescently Labeled Cetuximab
批准号:
8765574
负责人:
EBEN L. ROSENTHAL
金额:
$26.81万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2016-06-30
关键词:
AntibodiesBedsBlindedCetuximabCharacteristicsClinicClinical TrialsDataData AnalysesDetectionDevelopmentDiagnosticDiseaseDoseEGFR Protein OverexpressionEpidermal Growth Factor ReceptorEpitheliumEquipmentExcisionExplosionFDA approvedFluorescenceFrozen SectionsFundingHead and Neck CancerHumanImageImage-Guided SurgeryImageryImaging DeviceInflammatoryInstitutional Review BoardsLabelMalignant NeoplasmsMeasuresMicroscopicModelingOperating RoomsOperative Surgical ProceduresOutcomePatient SchedulesPatientsPre-Clinical ModelPrimary NeoplasmProceduresRecruitment ActivityResectedSafetySamplingSensitivity and SpecificitySpecimenSurgeonSurvival RateSystemTechniquesTherapeuticTherapeutic AgentsTherapeutic UsesTimeTissuesTongue NeoplasmsToxic effectTranslationsTumor Tissuecancer surgerycancer typeimprovedin vivoinnovationintraoperative imagingintravenous administrationnonhuman primatenoveloncologyoptical imagingpre-clinicalpublic health relevancereceptor expressionstandard of caretumortumor specificitywound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Evidence from our lab and others has demonstrated the potential of fluorescently labeled antibodies to measure microscopic disease to guide surgical intervention preclinical models. We present novel data demonstrating safety of the fluorescently labeled anti- EGFR antibody in non-human primates. We propose a clinical trial with fluorescently labeled cetuximab to detect subclinical cancer in the operating room existing imaging equipment to guide surgical resection of head and neck cancer. The proposed trial has received IRB and IND approval in September 2013.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
American Head and Neck International Conference
-
批准号:10753698
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2023
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
-
批准号:10671612
-
项目类别:
-
资助金额:$45.27万
-
财政年份:2022
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
-
批准号:10508399
-
项目类别:
-
资助金额:$42.6万
-
财政年份:2022
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Next Generation Sentinel Node Mapping
-
批准号:10532064
-
项目类别:
-
资助金额:$4.91万
-
财政年份:2019
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:9586709
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:10496780
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:9727786
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:10164616
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Prototype optical device for image guided surgery with panitumumab-IRDye800
-
批准号:8969649
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2015
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Prototype optical device for image guided surgery with panitumumab-IRDye800
-
批准号:9342705
-
项目类别:
-
资助金额:$58.5万
-
财政年份:2015
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Prototype optical device for image guided surgery with panitumumab-IRDye800
-
批准号:9759821
-
项目类别:
-
资助金额:$42.01万
-
财政年份:2015
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Optical imaging of primary and regional melanoma to guide surgical resection
-
批准号:8699170
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2013
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Optical imaging of primary and regional melanoma to guide surgical resection
-
批准号:8564734
-
项目类别:
-
资助金额:$19.17万
-
财政年份:2013
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
8th Annual Conference on Head and Neck Cancer
-
批准号:8319118
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2012
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8444266
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8621981
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8024535
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8225379
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:7899557
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Fluorescently Labeled Anti-EGFR to Guide Removal of Lymph Node Metastasis
-
批准号:7738795
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2009
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
海外基金